Source Naturals Beta Glucan

Beta Glucan is a unique polysaccharide composed of glucose molecules extracted and purified from the cell wall of common baker's yeast Saccharomyces cerevisiae. Beta glucan is used to maintain or stimulate the effectiveness of the immune system. Animal and human cell culture studies have shown that beta glucan can stimulate several aspects of immune function, such as phagocytosis and interleukin production. Source Naturals Beta Glucan uses a purification process that removes the manoproteins and yeast residues that may reduce the effectiveness of beta glucan.
High Quality products formulated by a medical
doctor

These include
Mind Power Rx for better mental focus, concentration, and mood; Diet Rx which helps you eat less. It really works to curb appetite; Good Night
Rx for better sleep; Eyesight
Rx with lots of antioxidants for better vision; MultiVit
Rx a daily comprehensive multivitamin for more energy and
vitality; Joint Power Rx
for healthy joints; Prostate Power Rx
for a healthy prostate gland; Passion Rx
for sexual enhancement in men and women; and
Veg Rx with Coq10 and carnitine supplies the missing nutrients in a
vegetarian diet.
Immune system and beta
glucan
The carbohydrate polymers known as beta-1,3-d-glucans exert potent effects on
the immune system - stimulating anti-tumor and antimicrobial activity, for example - by
binding to receptors on macrophages and other white blood cells and activating them.
Although beta-glucans are known to bind to receptors, such as complement receptor 3, there
is evidence that another beta-glucan receptor is present on macrophages.
Conditions where Beta Glucan
may be effective
Beta glucan may be helpful in
diabetes. The addition of beta-glucan
predictably reduces the Glycemic Index. In a 50 g carbohydrate portion each gram of
beta-glucan reduces the GI by 4 units, making it a useful functional food component for
reducing postprandial glycemia.
Beta Glucan, 250 mg., 60 Tablets Source Naturals
Beta-Glucan study for diabetes patients
Sweeteners and beta-glucans improve metabolic and anthropometrics variables in
well controlled type 2 diabetic patients.
Am J Ther. 2003 Nov-Dec;10(6):438-43.
Reyna NY. University of Zulia, Maracaibo,
Venezuela.
A total of 16 male, well controlled type 2 diabetes patients
were divided into two groups of eight; one group received the diet based on the
American Diabetic Association's nutrition recommendations, and the other was fed
a modified, low-calorie diet containing a fat replacer (beta-glucans derived
from oats) and the sweeteners, sucralose and fructose. Both groups were
maintained on their respective diets for 4 weeks. All patients performed daily
aerobic exercise consisting of walking for 60 minutes. Body weight, body mass
index, basal glycemia, hemoglobin HbA1C, and lipid profile were determined in
each patient before starting the diets and after 4 weeks of dietary
intervention. Both diets produced significant improvements in weight,
body mass index, lipid profile, basal glucose, and HbA1C. However, the
experimental diet was superior to the American Diabetic Association's diet in
improving metabolic and anthropometric profile: greater increase in HDL
cholesterol and larger decreases in HbA1C, weight, and body mass index.
A diet incorporating a beta-glucans and non-sucrose sweeteners
produced a greater improvement in metabolic and anthropometric variables in well
controlled type 2 diabetic patients when compared with a diet based on American
Diabetic Association's nutrition recommendations.
The effect of beta-glucan on the glycemic and insulin
index.
Eur J Clin Nutr. 2007 June . Mäkeläinen H, Anttila H, Sihvonen J, Hietanen
RM, Tahvonen R, Salminen E, Mikola M, Sontag-Strohm T. Functional Foods Forum,
University of Turku, Helsinki, Finland.
To determine the effects of oat products with increasing beta-glucan content on
the glycemic (GI) and insulin indexes (II) of oat products, and to establish the
effect of physical properties of beta-glucan on these physiological responses.
One male and nine female volunteers were recruited from university students and
staff, and all completed the study. GI and II of different products were
calculated for each subject using the average of parallel glucose tolerance
tests and the subsequent glycemic/insulinemic responses for each product.
Average indexes for products were calculated according to the individual data.
The glycemic responses to oat products with increasing amounts of beta-glucan
had lower peak values than the reference glucose load. The amount of extractable
beta-glucan had a high correlation between the glycemic and insulinemic
response. In addition to the total amount of beta-glucan in oat products, the
amount of extractable beta-glucan in oat products explains the magnitude of the
decrease in glycemic responses to carbohydrate products.
Beta glucan and blood lipids
Randomized controlled crossover study of the effect of a highly beta-glucan-enriched
barley on cardiovascular disease risk factors in mildly hypercholesterolemic
men.
Keogh GF, Cooper GJ,
Department of Medicine, the Human Nutrition & Metabolic Unit, University of
Auckland, New Zealand.
Soluble-fiber beta-glucan derived from oats can reduce
cardiovascular disease (CVD) risk through reductions in total and LDL
cholesterol. Barley-derived beta-glucan may also improve serum cholesterol, but
large quantities are required for clinical significance. This trial
investigated whether a beta-glucan-enriched form of barley can favorably modify
cholesterol and other markers of CVD and diabetes risk. Eighteen mildly hyperlipidemic ( +/- SD: 4.0 +/- 0.6 mmol LDL cholesterol/L) men with a mean
(+/- SD) body mass index (in kg/m(2)) of 27.4 +/- 4.6 were randomly assigned in
this single-blind, 2 x 4-wk trial to either the treatment arm [8.1-11.9 g beta-glucan/d
(scaled to body weight)] or the control arm (isoenergetic dose of 6.5-9.2 g
glucose/d). After a washout period of 4 wk, dietary regimens were crossed over.
The trial took place in a long-stay metabolic facility, and all foods were
provided (38% of energy from fat). Fasted blood samples were collected on days
0, 1, 7, 14, 21, 28, and 29 in both study arms. An oral-glucose-tolerance test
was carried out on days 0 and 29. RESULTS: There was no significant change
(Delta) in total (Delta = -0.08 mmol/L, -1.3%), LDL (Delta = -0.15 mmol/L,
-3.8%), or HDL (Delta = 0 mmol/L) cholesterol or in triacylglycerol (Delta =
0.18 mmol/L), fasting glucose (Delta = -0.05 mmol/L), or postprandial glucose
when analyzed between treatments (P > 0.05; ANOVA). The effect of
beta-glucan-enriched barley on lipid profile was highly variable between
subjects, and there was no evidence of a clinically significant improvement in
CVD risk across this group of mildly hyperlipidemic men.
Beta glucan and cholesterol
Cholesterol-lowering effect of beta-glucan from oat bran in mildly
hypercholesterolemic subjects may decrease when beta-glucan is incorporated into
bread and cookies.
Kerckhoffs DA. Maastricht University, Maastricht, The Netherlands.
Findings about the effects of beta-glucan on serum lipoproteins are
conflicting. OBJECTIVE: The study investigated the effects of beta-glucan from
oat bran in bread and cookies (study 1) and in orange juice (study 2) on serum
lipoproteins in mildly hypercholesterolemic subjects. In study 1, 48
subjects (21 men, 27 women) received for 3 wk control bread and cookies rich in
wheat fiber. For the next 4 wk, by random assignment, 23 subjects continued to
consume the control products, and 25 received bread and cookies rich in beta-glucan.
Mean daily intake of beta-glucan was 5.9 g. Total dietary fiber intake did not
differ significantly between the groups. In study 2, the same sources of control
fiber and beta-glucan (5 g/d) as in study 1 were provided. For 2 wk, 25 of the
original 48 subjects (10 men, 15 women) were randomly assigned to consume orange
juice containing either wheat fiber (n = 13) or beta-glucan from oat bran (n =
12). After a washout period of 1 wk, dietary regimens were crossed over.
RESULTS: In study 1, the change in LDL cholesterol did not differ significantly
(-0.12 mmol/L; P = 0.173) between the 2 groups. In study 2, the drink rich in
beta-glucan decreased LDL cholesterol by 0.26 +/- 0.07 mmol/L (6.7 +/- 1.8%; P =
0.001) and the ratio of total to HDL cholesterol by 0.26 +/- 0.11 (5.4 +/- 2.1%;
P = 0.029) compared with the other drink. HDL-cholesterol and triacylglycerol
concentrations did not change significantly. The food matrix or the
food processing, or both, could have adverse effects on the hypocholesterolemic
properties of oat beta-glucan.
Home - Tribulus terrestris extract
beta glucan study beta glucan benefits beta glucan and immune system beta glucan